Evolv Technologies vs Mitek Systems
EVLV and MITK side by side, both in computer and office equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EVLV and MITK compare
Evolv Technologies and Mitek Systems are about the same size, with market caps of $817M and $846M.
Evolv Technologies grew revenue faster over the last twelve months (28.9% versus 11.1% for Mitek Systems).
Mitek Systems keeps more of each dollar of sales as profit, with a net margin of 11.4% compared with −10.8% at Evolv Technologies.
Mitek Systems scores higher on the StockData Score (14 against 7 for Evolv Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EVLV | MITK |
|---|---|---|
| Size and price | ||
| Market cap | $817M | $846M |
| Share price | $4.51 | $18.74 |
| Change, 1 year | −37.2% | 101% |
| Change, 5 years | −26.8% | 4.1% |
| Beta (5Y) | 1.66 | 1.16 |
| Employees | 286 | 595 |
| StockData Score | ||
| Total score | 7 | 14 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 3 (better) | 2 |
| Performance score | 1 | 5 (better) |
| Health score | 3 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 39.9× |
| P/S | 4.6× | 4.3× (better) |
| P/B | 7.6× | 3.4× (better) |
| EV/EBITDA | – | 21.7× |
| P/FCF | – | 17.4× |
| PEG | – | 1.19 |
| FCF yield | – | 5.7% |
| Fair value | $3.83 | $17.12 |
| Margin of safety | −17.8% | −9.5% (better) |
| Growth | ||
| Revenue growth (TTM) | 28.9% (better) | 11.1% |
| Revenue growth, 5Y average | 93.5% (better) | 12.1% |
| Net income growth (TTM) | – | 45.3% |
| EPS growth (TTM) | – | 42.4% |
| EPS growth, 5Y average | – | 1.1% |
| Profitability | ||
| Gross margin | 49.9% | – |
| Operating margin | −23.5% | 17.8% (better) |
| Net margin | −10.8% | 11.4% (better) |
| FCF margin | – | 24.6% |
| Return on equity | −18.1% | 9.2% (better) |
| Return on invested capital | −45.4% | 18.6% (better) |
| Financial health | ||
| Debt / equity | 0.27 | 0.20 (better) |
| Net debt / EBITDA | – | −1.37 |
| Interest coverage | −10.5× | 4.9× (better) |
| Current ratio | 1.09 | 2.74 (better) |
| Altman Z-score | 0.76 | 5.43 (better) |
| Piotroski F-score | 4 | 7 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | 2.5% |
| Shareholder yield | 0.00% | 2.5% (better) |
| Ownership | ||
| Held by institutions | 66.9% | 85.5% |
| Held by insiders | 11.7% | 4.7% |
| Insider net buying, 12 months | −$6.2M | −$3.5M (better) |
| Short interest, % of float | 6.1% | 10.0% |
Go deeper
- EVLV stock overview
- EVLV income statement
- EVLV valuation and score
- MITK stock overview
- MITK income statement
- MITK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.